Over the last 7 days, the Biotech industry has risen 3.9%, driven by gains in ALTEOGEN and Celltrion of 16% and 5.6%, respectively. This takes the industry's 12 month performance to a gain of 37%. Earnings are forecast to grow by 53% annually.
Has the South Korean Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | ₩90.5t | ₩9.9t | -₩651,620,427,048.00 | 23.3x | -138.8x | 9.2x |
Sun, 23 Jun 2024 | ₩83.5t | ₩9.9t | -₩651,620,427,048.00 | 22.3x | -128.1x | 8.5x |
Tue, 21 May 2024 | ₩81.6t | ₩9.6t | -₩558,637,135,118.00 | 23.5x | -146.1x | 8.5x |
Thu, 18 Apr 2024 | ₩76.2t | ₩9.6t | -₩574,854,220,678.00 | 21.8x | -132.5x | 7.9x |
Sat, 16 Mar 2024 | ₩81.5t | ₩9.7t | -₩488,940,834,667.00 | 57.5x | -166.6x | 8.4x |
Mon, 12 Feb 2024 | ₩73.3t | ₩9.7t | -₩537,261,689,777.00 | 62.6x | -136.4x | 7.5x |
Wed, 10 Jan 2024 | ₩68.0t | ₩10.1t | -₩324,278,048,367.00 | 29.8x | -209.8x | 6.7x |
Fri, 08 Dec 2023 | ₩57.4t | ₩10.1t | -₩309,980,431,097.00 | 28.7x | -185.1x | 5.7x |
Sun, 05 Nov 2023 | ₩54.2t | ₩10.2t | -₩239,053,318,689.00 | 30.2x | -226.6x | 5.3x |
Tue, 03 Oct 2023 | ₩55.5t | ₩10.2t | -₩239,053,318,689.00 | 28.3x | -232.1x | 5.4x |
Thu, 31 Aug 2023 | ₩58.6t | ₩10.1t | -₩370,027,403,829.00 | 35.6x | -158.4x | 5.8x |
Sat, 29 Jul 2023 | ₩54.8t | ₩10.3t | -₩151,534,704,579.00 | 26.4x | -361.5x | 5.3x |
Mon, 26 Jun 2023 | ₩59.4t | ₩10.3t | -₩151,534,704,579.00 | 29.8x | -391.7x | 5.8x |
Wed, 24 May 2023 | ₩64.5t | ₩10.6t | ₩148.8b | 39.9x | 433.8x | 6.1x |
Fri, 21 Apr 2023 | ₩62.5t | ₩11.0t | ₩317.9b | 23.7x | 196.5x | 5.7x |
Sun, 19 Mar 2023 | ₩57.4t | ₩11.4t | ₩945.0b | 27.3x | 60.8x | 5x |
Tue, 14 Feb 2023 | ₩59.4t | ₩11.3t | ₩970.8b | 24.7x | 61.2x | 5.2x |
Thu, 12 Jan 2023 | ₩59.6t | ₩11.4t | ₩685.0b | 22.8x | 87.1x | 5.2x |
Sat, 10 Dec 2022 | ₩61.7t | ₩10.8t | ₩197.3b | 24.1x | 312.6x | 5.7x |
Mon, 07 Nov 2022 | ₩60.5t | ₩10.8t | ₩348.0b | 18.7x | 173.8x | 5.6x |
Wed, 05 Oct 2022 | ₩57.9t | ₩10.8t | ₩392.8b | 20.9x | 147.3x | 5.3x |
Fri, 02 Sep 2022 | ₩67.2t | ₩10.9t | ₩499.8b | 23.9x | 134.5x | 6.2x |
Sun, 31 Jul 2022 | ₩70.1t | ₩10.7t | ₩597.6b | 26.2x | 117.2x | 6.6x |
Tue, 28 Jun 2022 | ₩65.0t | ₩10.7t | ₩597.6b | 23.6x | 108.7x | 6.1x |
Thu, 26 May 2022 | ₩67.4t | ₩10.4t | ₩782.3b | 26.2x | 86.1x | 6.5x |
Sat, 23 Apr 2022 | ₩69.0t | ₩10.0t | ₩866.3b | 27.1x | 79.6x | 6.9x |
Mon, 21 Mar 2022 | ₩78.5t | ₩9.9t | ₩870.7b | 31.9x | 90.2x | 8x |
Wed, 16 Feb 2022 | ₩68.6t | ₩9.4t | ₩787.4b | 32.5x | 87.2x | 7.3x |
Fri, 14 Jan 2022 | ₩87.3t | ₩9.4t | ₩787.4b | 38.3x | 110.9x | 9.3x |
Sun, 12 Dec 2021 | ₩96.8t | ₩9.4t | ₩780.3b | 41.4x | 124.1x | 10.3x |
Tue, 09 Nov 2021 | ₩92.7t | ₩9.2t | ₩988.3b | 40.7x | 93.8x | 10.1x |
Thu, 07 Oct 2021 | ₩93.5t | ₩9.2t | ₩986.0b | 37x | 94.8x | 10.2x |
Sat, 04 Sep 2021 | ₩126.1t | ₩9.3t | ₩909.7b | 47.8x | 138.6x | 13.6x |
Mon, 02 Aug 2021 | ₩107.9t | ₩9.3t | ₩909.7b | 50x | 118.6x | 11.6x |
118.6x
Which industries have driven the changes within the South Korean Healthcare industry?
KR Market | -3.99% | |
Healthcare | 1.34% | |
Biotech | 3.92% | |
Biotech | 3.92% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A196170 ALTEOGEN | ₩304.50k | 15.8% +₩2.2t | 604.0% | PE633.3x | |
A068270 Celltrion | ₩198.50k | 5.6% +₩2.2t | 37.8% | PE104x | |
A145020 Hugel | ₩246.50k | 12.6% +₩301.8b | 139.8% | PE27.7x | |
A086900 Medy-Tox | ₩187.00k | 20.0% +₩210.0b | -12.6% | PE718.9x | |
A310210 Voronoi | ₩79.00k | 9.3% +₩116.5b | 73.3% | PB17.5x |